Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 1 OF 195 | DISPLAYING 1 - 15 OF 2921 RESULTS

    Das K et al., Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue., , Methods Mol Biol, Jan 01, 2020

    Cesano A et al., Status of Immune Oncology: Challenges and Opportunities., , Methods Mol Biol, Jan 01, 2020

    Beechem JM et al., High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-oncology Biomarker Discovery and Translational Research., , Methods Mol Biol, Jan 01, 2020

    Bhattacharya D et al., Control of neural crest multipotency by Wnt signaling and the Lin28/let-7 axis., , eLife, Dec 06, 2019

    Damotte D et al., The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort., , J Transl Med., Nov 04, 2019

    Giannini R et al., Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like., , J Clin Endocrinol Metab, Oct 28, 2019

    Nixon MJ et al., PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer., , NPJ Breast Cancer, Sep 23, 2019

    Leong JY et al., Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFalpha withdrawal., , Ann Rheum Dis, Sep 20, 2019

    Schreiber LM et al., The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer., , Br J Cancer, Sep 18, 2019

    Ronsley R et al., The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study., , Pediatr Hematol Oncol, Sep 18, 2019

    Kwon DH et al., Glutathione Induced Immune-Stimulatory Activity by Promoting M1-Like Macrophages Polarization via Potential ROS Scavenging Capacity., , Antioxidants (Basel), Sep 18, 2019

    Adamo B et al., Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial., , Breast Cancer Res, Sep 18, 2019

    Octeau D et al., Outcome-Related Differences in Gene Expression Profiles of High Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy., , Mol Cancer Res, Sep 17, 2019

    Tambalo M et al., Enhancer activation by FGF signalling during otic induction., , Dev Biol, Sep 17, 2019

    Staiger AM et al., A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL., , Leukemia, Sep 17, 2019